Sinohealth Technology Holdings Limited (Sinohealth Tech, 02361) has issued a notice convening its Annual General Meeting (AGM) for 18 June 2026 at 3:00 p.m. in Hong Kong’s Rykadan Tower. Key items to be put before shareholders are outlined below.
Dividend Proposal • Shareholders will vote on a final dividend of HK7.12 cents per share for the financial year ended 31 December 2025.
Board and Auditor Matters • Re-election of three directors: Executive Chairman Mr Wu Yushu, Non-executive Director Mr Fu Haitao and Independent Non-executive Director Ms Chui Hoi Yam. • Ernst & Young is nominated for re-appointment as external auditor, with the audit fee for the FY 2026 engagement estimated at RMB2.10 million–2.40 million. • The board will be authorised to fix remuneration for both directors and auditor.
Capital Mandates • General mandate to issue, allot or deal with shares—up to 20% of the company’s issued share capital (excluding any treasury shares) as at the date of approval. • General mandate to repurchase shares—capped at 10% of issued shares. • Extension mandate—size of the issuance mandate may be increased by the number of shares repurchased under the buy-back mandate, effectively allowing a potential additional 10% capacity.
Corporate Governance Amendment • A special resolution seeks adoption of a fifth amended and restated Memorandum and Articles of Association, consolidating proposed changes detailed in the circular dated 24 April 2026.
Key Timetable • Book closure: 15–18 June 2026 (both days inclusive); last day to lodge share transfers is 12 June 2026 by 4:30 p.m. • Proxy forms must be filed with Boardroom Share Registrars (HK) Limited at least 48 hours before the meeting.
The board currently comprises six directors: two executive (Mr Wu Yushu, Ms Wang Lifang), one non-executive (Mr Fu Haitao) and three independent non-executive (Ms Wang Danzhou, Ms Chui Hoi Yam, Mr Wei Bin).
Comments